Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Nov 27:12:169.
doi: 10.1186/1471-230X-12-169.

Marginal turbid band and light blue crest, signs observed in magnifying narrow-band imaging endoscopy, are indicative of gastric intestinal metaplasia

Affiliations
Clinical Trial

Marginal turbid band and light blue crest, signs observed in magnifying narrow-band imaging endoscopy, are indicative of gastric intestinal metaplasia

Jin Kwang An et al. BMC Gastroenterol. .

Abstract

Background: Gastric intestinal metaplasia (IM) usually appears in flat mucosa and shows few morphologic changes, making diagnosis using conventional endoscopy unreliable. Magnifying narrow-band imaging (NBI) endoscopy enables evaluation of detailed morphological features that correspond with the underlying histology. The aim of this study was to investigate and clarify the diagnostic efficacy of magnifying NBI endoscopic findings for the prediction and diagnosis of IM.

Methods: Forty-seven patients were prospectively enrolled, and magnifying NBI examinations were performed in the lesser curvature of the midbody and the greater curvature of the upper body. The marginal turbid band (MTB) was defined as an enclosing white turbid band on the epithelial surface/gyri; light blue crest (LBC), as a fine, blue-white line on the crest of the epithelial surface/gyri. Immediately after observation under magnifying endoscopy, biopsy specimens were obtained from the evaluated areas.

Results: The degree of IM significantly increased with increasing MTB/LBC positivity (MTB(-)/LBC(-), 0.00 ± 0.00; MTB(+)/LBC(-), 0.44 ± 0.51; MTB(+)/LBC(+), 0.94 ± 0.24; p < 0.001). Moderate-to-severe IM was more common in MTB(+)/LBC(+) areas than in MTB(+)/LBC(-) areas (p < 0.001). For the diagnosis of IM, MTB had a sensitivity, specificity, and accuracy of 100%, 66.0%, and 81.7%, respectively, and the corresponding values for LBC were 72.1%, 96.0%, and 84.9%.

Conclusion: MTB and LBC observed in the gastric mucosa with magnifying NBI endoscopy are highly accurate indicators of the presence of IM. MTB likely represents a sign of early gastric IM, while LBC appears with progression to severe IM.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic figure for marginal turbid band and light blue crest. The marginal turbid band is defined as an enclosing, white turbid band on the epithelial surface/gyri, and light blue crest is defined as a fine, blue-white line on the crest of the epithelial surface/gyri.
Figure 2
Figure 2
Magnifying NBI endoscopic findings and representative histological findings. A Uniform round pits surrounded by a regular honeycomb subepithelial network and a regular arrangement of collecting venules are seen. No marginal turbid band (MTB) or light blue crest (LBC) is observed. B Histological view showing no atrophy or intestinal metaplasia. C Regular honeycomb subepithelial network and collecting venules subside. MTBs are seen (arrow), but LBC is shadowy. D Histological view illustrating a mild degree of intestinal metaplasia and atrophy. E Both MTBs are LBCs are distinctly visible (arrow). F Histological view showing moderate to severe mucosal atrophy and intestinal metaplasia.
Figure 3
Figure 3
A, B The relationship between magnifying NBI endoscopic findings and histological findings. There were significant differences in the grades of atrophy (p < 0.001) and intestinal metaplasia (p < 0.001) among the 3 groups categorized by the presence of marginal turbid band (MTB) and light blue crest (LBC).

Similar articles

Cited by

References

    1. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48(13):3554–3560. - PubMed
    1. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut. 1991;32(10):1110–1113. doi: 10.1136/gut.32.10.1110. - DOI - PMC - PubMed
    1. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Lara-Santos L, Guilherme M, Moreira-Dias L. et al.Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc. 2003;57(4):498–504. doi: 10.1067/mge.2003.145. - DOI - PubMed
    1. Meining A, Rosch T, Kiesslich R, Muders M, Sax F, Heldwein W. Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction. Endoscopy. 2004;36(2):160–164. doi: 10.1055/s-2004-814183. - DOI - PubMed
    1. Sauerbruch T, Schreiber MA, Schussler P, Permanetter W. Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histological diagnosis. Endoscopy. 1984;16(3):101–104. doi: 10.1055/s-2007-1018546. - DOI - PubMed

Publication types

LinkOut - more resources